Yerace Daniel Alexander 4
4 · Coeptis Therapeutics Holdings, Inc. · Filed Jan 31, 2023
Insider Transaction Report
Form 4
Yerace Daniel Alexander
DirectorVP Operations
Transactions
- Award
Incentive Stock Options (right to buy)
2023-01-27+200,000→ 200,000 totalExercise: $1.60→ Common Stock (200,000 underlying)
Footnotes (4)
- [F1]On January 27, 2023, the reporting person received a grant of 200,000 incentive stock options, under the 2022 equity incentive plan.
- [F2]The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.
- [F3]Options will vest over 4 years, with the first 25% vesting on 12/31/23, and the balance vesting in equal quarterly installments over the succeeding three years, with the final options vesting on 12/31/26.
- [F4]Expiration date is ten years from the day of grant.